199 related articles for article (PubMed ID: 2539926)
1. Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertension.
Seccombe DW; Pudek MR; Nowaczynski W; Humphries KH
Clin Biochem; 1989 Feb; 22(1):17-21. PubMed ID: 2539926
[TBL] [Abstract][Full Text] [Related]
2. Comparison between endogenous digoxin-like immunoreactivity and 86Rb uptake by erythrocytes in extracts of human plasma.
Balzan S; Montali U; Genovesi-Ebert A; Biver P; Fantoni M; Ghione S
Clin Sci (Lond); 1989 Oct; 77(4):375-81. PubMed ID: 2553327
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography.
De Angelis C; Riscazzi M; Salvini R; Piccoli A; Ferri C; Santucci A
Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322
[TBL] [Abstract][Full Text] [Related]
5. The contribution of steroids to digoxin-like immunoreactivity in cord blood.
Yun WS; Ho CS; Panesar NS; Swaminathan R
Ann Clin Biochem; 1992 May; 29 ( Pt 3)():337-42. PubMed ID: 1319129
[TBL] [Abstract][Full Text] [Related]
6. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
[TBL] [Abstract][Full Text] [Related]
7. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
[TBL] [Abstract][Full Text] [Related]
8. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
[TBL] [Abstract][Full Text] [Related]
9. Endogenous digoxin-like activity of mammalian-lignans and their derivatives.
Hirano T; Oka K; Naitoh T; Hosaka K; Mitsuhashi H
Res Commun Chem Pathol Pharmacol; 1989 May; 64(2):227-40. PubMed ID: 2544967
[TBL] [Abstract][Full Text] [Related]
10. A study into the nature and organ source of digoxin-like immunoreactive substance(s) in the perinatal period.
Seccombe DW; Pudek MR; Humphries KH; Matthewson B; Taylor GP; Jacobson BE; Whitfield MP
Biol Neonate; 1989; 56(3):136-46. PubMed ID: 2553137
[TBL] [Abstract][Full Text] [Related]
11. Ouabainlike factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
[TBL] [Abstract][Full Text] [Related]
12. Digoxin-like immunoreactivity in cord blood plasma extracts is not only due to endogenous corticosteroids.
Yiannakou L; Loucari-Yiannakou E; Souvatzoglou A
Clin Biochem; 1991 Dec; 24(6):475-82. PubMed ID: 1773487
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids.
Pullen MA; Brooks DP; Edwards RM
J Pharmacol Exp Ther; 2004 Jul; 310(1):319-25. PubMed ID: 14982968
[TBL] [Abstract][Full Text] [Related]
14. A quantitative receptor assay for "digitalis-like" compounds in serum. Demonstration of raised concentrations in essential hypertension and correlation with arterial blood pressure.
Moreth K; Renner D; Schoner W
Klin Wochenschr; 1987 Feb; 65(4):179-84. PubMed ID: 3031360
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of human urine-derived digitalis-like factor.
Goto A; Yamada K; Ishii M; Yoshioka M; Ishiguro T; Eguchi C; Sugimoto T
Biochem Biophys Res Commun; 1988 Aug; 154(3):847-53. PubMed ID: 2841934
[TBL] [Abstract][Full Text] [Related]
16. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH
Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
[TBL] [Abstract][Full Text] [Related]
17. Partial purification and properties of a plasma ouabain-like inhibitor of Na+, K+-ATPase in patients with essential hypertension.
Masugi F; Ogihara T; Sakaguchi K; Tomii A; Hasegawa T; Chen Y; Azuma M; Kumahara Y
J Hypertens Suppl; 1988 Dec; 6(4):S351-3. PubMed ID: 2853743
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of the presence of digoxin-like immunoreactive substance (DLIS) in the serum and urine in children with nephrotic syndrome.
Shimabukuro N; Ebara H; Maruyama K; Tomizawa S; Kuroume T
Clin Nephrol; 1988 May; 29(5):244-7. PubMed ID: 2840225
[TBL] [Abstract][Full Text] [Related]
19. Digoxin-like immunoreactivity: is it still worth measuring?
Goto A; Yamada K; Yagi N; Hui C; Sugimoto T
Life Sci; 1991; 49(23):1667-78. PubMed ID: 1658518
[TBL] [Abstract][Full Text] [Related]
20. Effects of human urine-derived digitalis-like factor on cultured renal tubular epithelial cells.
Goto A; Yamada K; Ishii M; Yoshioka M; Ishiguro T; Eguchi C; Sugimoto T
J Hypertens Suppl; 1988 Dec; 6(4):S287-9. PubMed ID: 2853736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
